Yin Yang

Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection.

C. Stedman, E. Gane, D. Brainard, 2017, Gastroenterology.

Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections.

C. Stedman, E. Gane, D. Brainard, 2016, Gastroenterology.

Sofosbuvir‐velpatasvir‐voxilaprevir with or without ribavirin in direct‐acting antiviral–experienced patients with genotype 1 hepatitis C virus

H. Dvory‐Sobol, D. Brainard, J. McHutchison, 2017, Hepatology.